BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37147713)

  • 1. SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.
    Li Z; Tao Y; Gao Z; Peng S; Lai Y; Li K; Chen X; Huang H
    J Transl Med; 2023 May; 21(1):303. PubMed ID: 37147713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
    Li Y; Gao Y; Xu Y; Ma H; Yang M
    Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
    He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
    Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
    Xu W; Chang J; Du X; Hou J
    Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CDKN2B-AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis.
    Zhu JL; Xue WB; Jiang ZB; Feng W; Liu YC; Nie XY; Jin LY
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1144-1154. PubMed ID: 36161699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.
    Xiao P; Liu W; Zhou H
    Mol Med Rep; 2016 Aug; 14(2):1835-40. PubMed ID: 27356635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑663 suppresses the proliferation and invasion of colorectal cancer cells by directly targeting FSCN1.
    Yu S; Xie H; Zhang J; Wang D; Song Y; Zhang S; Zheng S; Wang J
    Mol Med Rep; 2017 Dec; 16(6):9707-9714. PubMed ID: 29039557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y; Yang X; Wu H; Zhou W; Liu Z
    Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
    Chang D; Liu XX; Liu R; Sun JW
    Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis.
    Nan-Li ; Zhang ZD; Li RR; Chen JY; Huang HX; Cheng YW; Xu LY; Li EM
    Amino Acids; 2022 Dec; 54(12):1541-1552. PubMed ID: 35939077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
    Lai C; Chen Z; Li R
    Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
    Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
    J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
    Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.
    Wang Q; Wang LX; Zhang CY; Bai N; Feng C; Zhang ZM; Wang L; Gao ZZ
    Mol Cell Biochem; 2022 May; 477(5):1477-1488. PubMed ID: 35166986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
    Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
    Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.